[Current views on the pathogenesis and pharmacotherapy of Parkinson disease].
Kostowski
W
W
Zakładu Farmakologii i Fizjologii Układu Nerwowego Instytutu Psychiatrii i Neurologii w Warszawie.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000172:deficiency; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy / Q000209:etiology*; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism; D011963:Receptors, GABA-A / Q000187:drug effects / Q000378:metabolism; D013378:Substantia Nigra / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000172:deficiency
D000978:Antiparkinson Agents; D011954:Receptors, Dopamine; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid; D004298:Dopamine
Współczesne poglady na patogeneze i farmakoterapie choroby Parkinsona.